Every material Form 8-K Visteon filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Visteon reported third-quarter 2025 net sales of $917 million, down 6% from a year earlier, while net income attributable to Visteon rose to $57 million from $39 million and diluted EPS rose to $2.04 from $1.40. Adjusted EPS fell to $2.15 from $2.26, and the company kept its full-year 2025 guidance, saying sales are tracking below the midpoint of the range.
Q3 2025 net sales were $917 million, down 6% year over year, driven by lower Battery Management Systems sales in the U.S., weaker sales in China and unplanned JLR downtime in September
Diluted EPS was $2.04 versus $1.40 a year earlier; adjusted EPS was $2.15 versus $2.26
Full-year 2025 guidance maintained: sales of $3.70 billion to $3.85 billion, adjusted EBITDA of $475 million to $505 million, adjusted free cash flow of $195 million to $225 million; sales tracking below midpoint
Net cash was $459 million at September 30, 2025; the company paid its first quarterly dividend
Visteon reported second-quarter 2025 sales of $969 million, down from $1,014 million a year earlier, and net income attributable to the company of $65 million, down from $71 million. The company raised its full-year 2025 sales, adjusted EBITDA and adjusted free cash flow guidance and initiated a quarterly dividend of $0.275 per share, which shareholders may weigh against the lower quarterly sales and profit.
Q2 2025 sales were $969 million versus $1,014 million in Q2 2024; diluted EPS was $2.36 versus $2.54.
Full-year 2025 guidance: sales $3.70 billion to $3.85 billion (up from $3.65 billion to $3.85 billion); adjusted EBITDA $475 million to $505 million (up from $450 million to $480 million).
Board approved a quarterly dividend of $0.275 per share, payable September 5, 2025, to holders of record on August 18, 2025.
Company paused share repurchases in Q2 due to tariff uncertainty and plans to resume capital returns opportunistically.
Visteon Corporation appointed Marjorie Sennett to its board of directors effective immediately, with the board approving her election on July 17, 2025. She will also serve on the Audit Committee and the Organization and Compensation Committee, and the board determined she meets independence requirements. The filing discloses no financial results, guidance, or compensation figures beyond a prorated stock unit award and annual cash retainer.
Board approved Marjorie Sennett's election on July 17, 2025, effective immediately
Sennett will serve on both the Audit Committee and the Organization and Compensation Committee
Her compensation includes a stock unit award under the 2020 Incentive Plan and a prorated annual cash retainer
Sennett previously served as CFO at eGroups and Amylin Pharmaceuticals and currently sits on the Cognex board
Visteon reported first quarter 2025 net sales of $934 million, up slightly from $933 million a year earlier, and net income attributable to the company of $65 million, up from $42 million. The company did not reaffirm its full-year 2025 guidance, citing uncertainty from tariffs, and said it will update guidance once visibility improves.
Net income attributable to Visteon was $65 million, or $2.36 per diluted share, versus $42 million, or $1.50 per diluted share, in Q1 2024
Adjusted EBITDA was $129 million, up from $102 million; sales were $934 million versus $933 million
Visteon is not reaffirming full-year 2025 guidance and will update it once visibility improves
Cash ended the quarter at $658 million and debt at $315 million, a net cash position of $343 million
Visteon reported fourth-quarter and full-year 2024 results in which net sales and GAAP net income declined from 2023, while adjusted EBITDA reached a record for the full year. The company also issued 2025 guidance for sales, adjusted EBITDA and adjusted free cash flow, and the compensation committee approved officer pay increases effective April 1, 2025.
Q4 2024 net sales were $939 million versus $990 million a year earlier, and diluted EPS was $4.37 versus $12.98.
Full-year 2024 net sales were $3,866 million versus $3,954 million, and net income was $274 million versus $486 million, with diluted EPS of $9.82 versus $17.05.
Full-year 2024 adjusted EBITDA was a record $474 million versus $434 million in 2023. 2025 guidance is sales of $3.65 billion to $3.85 billion and adjusted EBITDA of $450 million to $480 million, excluding any 2025 tariff impact.
On February 16, 2025, the committee approved pay increases for certain officers, including a $1,150,000 base salary and $10,000,000 long-term incentive award for CEO Sachin Lawande.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Visteon filing is on SEC EDGAR ↗. 8-K briefs of other companies →